These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34352414)

  • 1. Novel partial loss-of-function variants in the tyrosyl-tRNA synthetase 1 (YARS1) gene involved in multisystem disease.
    Estève C; Roman C; DeLeusse C; Baravalle M; Bertaux K; Blanc F; Bourgeois P; Bresson V; Cano A; Coste ME; Delteil C; Lacoste C; Loosveld M; De Paula AM; Monnier AS; Secq V; Levy N; Badens C; Fabre A
    Eur J Med Genet; 2021 Oct; 64(10):104294. PubMed ID: 34352414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recurrent missense mutation p.(Arg367Trp) in YARS1 causes a distinct neurodevelopmental phenotype.
    Averdunk L; Sticht H; Surowy H; Lüdecke HJ; Koch-Hogrebe M; Alsaif HS; Kahrizi K; Alzaidan H; Alawam BS; Tohary M; Kraus C; Endele S; Wadman E; Kaplan JD; Efthymiou S; Najmabadi H; Reis A; Alkuraya FS; Wieczorek D
    J Mol Med (Berl); 2021 Dec; 99(12):1755-1768. PubMed ID: 34536092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel multisystem disease associated with recessive mutations in the tyrosyl-tRNA synthetase (YARS) gene.
    Nowaczyk MJ; Huang L; Tarnopolsky M; Schwartzentruber J; Majewski J; Bulman DE; ; Hartley T; Boycott KM
    Am J Med Genet A; 2017 Jan; 173(1):126-134. PubMed ID: 27633801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: A new case of
    Kuan J; Hansen A; Wang H
    Front Pediatr; 2023; 11():1282253. PubMed ID: 38125821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease.
    Williams KB; Brigatti KW; Puffenberger EG; Gonzaga-Jauregui C; Griffin LB; Martinez ED; Wenger OK; Yoder MA; Kandula VVR; Fox MD; Demczko MM; Poskitt L; Furuya KN; Reid JG; Overton JD; Baras A; Miles L; Radhakrishnan K; Carson VJ; Antonellis A; Jinks RN; Strauss KA
    Hum Mol Genet; 2019 Feb; 28(4):525-538. PubMed ID: 30304524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling.
    Ermanoska B; Asselbergh B; Morant L; Petrovic-Erfurth ML; Hosseinibarkooie S; Leitão-Gonçalves R; Almeida-Souza L; Bervoets S; Sun L; Lee L; Atkinson D; Khanghahi A; Tournev I; Callaerts P; Verstreken P; Yang XL; Wirth B; Rodal AA; Timmerman V; Goode BL; Godenschwege TA; Jordanova A
    Nat Commun; 2023 Mar; 14(1):999. PubMed ID: 36890170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methionyl-tRNA synthetase gene variants/phenotypes in interstitial lung and liver disease: A case report and review of literature.
    Abuduxikuer K; Feng JY; Lu Y; Xie XB; Chen L; Wang JS
    World J Gastroenterol; 2018 Sep; 24(36):4208-4216. PubMed ID: 30271085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep phenotyping of MARS1 (interstitial lung and liver disease) and LARS1 (infantile liver failure syndrome 1) recessive multisystemic disease using Human Phenotype Ontology annotation: Overlap and differences. Case report and review of literature.
    La Fay C; Hoebeke C; Juzaud M; Spraul A; Heux P; Dubus JC; Hadchouel A; Fabre A
    Eur J Med Genet; 2021 Nov; 64(11):104334. PubMed ID: 34496286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
    Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
    Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A missense, loss-of-function
    Forrest ME; Meyer AP; Laureano Figueroa SM; Antonellis A
    Cold Spring Harb Mol Case Stud; 2022 Dec; 8(7):. PubMed ID: 36307205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.
    Rips J; Meyer-Schuman R; Breuer O; Tsabari R; Shaag A; Revel-Vilk S; Reif S; Elpeleg O; Antonellis A; Harel T
    Eur J Med Genet; 2018 Oct; 61(10):616-620. PubMed ID: 29655802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound heterozygosity for loss-of-function GARS variants results in a multisystem developmental syndrome that includes severe growth retardation.
    Oprescu SN; Chepa-Lotrea X; Takase R; Golas G; Markello TC; Adams DR; Toro C; Gropman AL; Hou YM; Malicdan MCV; Gahl WA; Tifft CJ; Antonellis A
    Hum Mutat; 2017 Oct; 38(10):1412-1420. PubMed ID: 28675565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating amino acid conservation with function in tyrosyl-tRNA synthetase.
    Xin Y; Li W; Dwyer DS; First EA
    J Mol Biol; 2000 Oct; 303(2):287-98. PubMed ID: 11023793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical functions of human cytoplasmic tyrosyl-, tryptophanyl- and other aminoacyl-tRNA synthetases.
    Wakasugi K; Yokosawa T
    Enzymes; 2020; 48():207-242. PubMed ID: 33837705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy.
    Friedman J; Smith DE; Issa MY; Stanley V; Wang R; Mendes MI; Wright MS; Wigby K; Hildreth A; Crawford JR; Koehler AE; Chowdhury S; Nahas S; Zhai L; Xu Z; Lo WS; James KN; Musaev D; Accogli A; Guerrero K; Tran LT; Omar TEI; Ben-Omran T; Dimmock D; Kingsmore SF; Salomons GS; Zaki MS; Bernard G; Gleeson JG
    Nat Commun; 2019 Feb; 10(1):707. PubMed ID: 30755602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant Intermediate Charcot-Marie-Tooth disorder is not due to a catalytic defect in tyrosyl-tRNA synthetase.
    Froelich CA; First EA
    Biochemistry; 2011 Aug; 50(33):7132-45. PubMed ID: 21732632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric assays for monitoring tRNA aminoacylation and aminoacyl-tRNA hydrolysis reactions.
    First EA; Richardson CJ
    Methods; 2017 Jan; 113():3-12. PubMed ID: 27780756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells.
    Blocquel D; Sun L; Matuszek Z; Li S; Weber T; Kuhle B; Kooi G; Wei N; Baets J; Pan T; Schimmel P; Yang XL
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19440-19448. PubMed ID: 31501329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A continuous tyrosyl-tRNA synthetase assay that regenerates the tRNA substrate.
    Richardson CJ; First EA
    Anal Biochem; 2015 Oct; 486():86-95. PubMed ID: 25998103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactive Editing Domain Variants Switch the Stereospecificity of Tyrosyl-tRNA Synthetase.
    Richardson CJ; First EA
    Biochemistry; 2016 May; 55(17):2526-37. PubMed ID: 27064538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.